Literature DB >> 13017478

Value of intra-articular injections in osteo-arthritis.

M H L DESMARAIS.   

Abstract

Entities:  

Keywords:  OSTEOARTHRITIS/therapy

Mesh：

Year:  1952        PMID： 13017478      PMCID： PMC1030607          DOI： 10.1136/ard.11.4.277

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  A Check on the Anatomical Accuracy of Intra-Articular Hip Injections in Relation to the Therapy of Coxarthritis.

Authors:  M M Dobson
Journal:  Ann Rheum Dis       Date:  1948       Impact factor: 19.103

2.  Treatment of osteoarthritis by lactic acid injection; a series of 26 consecutive cases in general practice.

Authors:  R MAWSON
Journal:  Br Med J       Date:  1946-11-09
  2 in total
  6 in total

1.  Intra-articular therapy in osteo-arthritis; comparison of hydrocortisone acetate and hydrocortisone tertiary-butylacetate.

Authors:  V WRIGHT; G N CHANDLER; R A MORISON; S J HARTFALL
Journal:  Ann Rheum Dis       Date:  1960-09       Impact factor: 19.103

2.  Pilot study of intra-articular procaine and hydrocortisone acetate in rheumatoid arthritis.

Authors:  G R FEARNLEY; R LACKNER; R I MEANOCK; E G BYWATERS
Journal:  Ann Rheum Dis       Date:  1956-06       Impact factor: 19.103

3.  Local injection of hydrocortisone and procaine in osteo-arthritis of the hip joint.

Authors:  V M LEVEAUX; C E QUIN
Journal:  Ann Rheum Dis       Date:  1956-12       Impact factor: 19.103

4.  Intra-articular hyaluronan treatment for osteoarthritis.

Authors:  E George
Journal:  Ann Rheum Dis       Date:  1998-11       Impact factor: 19.103

5.  [Polyarthritis and femoral head necrosis. Can long-term cortisone therapy lead to serious joint damage?].

Authors:  A Rütt
Journal:  Arch Orthop Unfallchir       Date:  1966

6.  A single intra-articular injection of 2.0% non-chemically modified sodium hyaluronate vs 0.8% hylan G-F 20 in the treatment of symptomatic knee osteoarthritis: A 6-month, multicenter, randomized, controlled non-inferiority trial.

Authors:  Emmanuel Maheu; Bernard Avouac; Renée Liliane Dreiser; Thomas Bardin
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.